(AGENPARL) – gio 27 aprile 2023 Hansa Biopharma and Genethon announce collaboration to develop imlifidase as pre-treatment to gene therapy…
Browsing: imlifidase
(AGENPARL) – lun 02 gennaio 2023 Hansa Biopharma announces positive reimbursement decision for Idefirix® (imlifidase) in the Czech Republic -…
(AGENPARL) – ven 09 dicembre 2022 Hansa Biopharma announces positive reimbursement decision in Italy for Idefirix® (imlifidase) as desensitization treatment…
(AGENPARL) – lun 28 novembre 2022 6.00 PM CET / 28-Nov-2022 / Hansa Biopharma AB (STO:HNSA) Hansa Biopharma announces positive…
(AGENPARL) – mer 02 novembre 2022 9.30 PM CET / 2-Nov-2022 / Hansa Biopharma AB (STO:HNSA) Hansa Biopharma and partner…